SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead Vt Regulatory News (BVT)

Share Price Information for Baronsmead Vt (BVT)

Share Price is delayed by 15 minutes
Get Live Data
45.00    0.00 (0.00%)
Bid:
44.00
Ask:
46.00
Spread: 2.00 (4.545%)
Market Cap: £203.60m
BVT Live PriceLast checked at - London Stock Exchange

Intraday Baronsmead Vt Share Chart

Update on Offer for Subscription

26 Nov 2024 14:00

RNS Number : 7237N
Baronsmead Venture Trust PLC
26 November 2024
 

 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

 

Baronsmead Venture Trust plc

LEI: 213800VQ1PQHOJXDDQ88

26 November 2024

 

Update on Offer for Subscription

Following the announcement made on 1 October 2024 of an intention to fundraise by Baronsmead Venture Trust plc (the "Company"), the Board of the Company has discussed the size and structure of the proposed offer for subscription, which the Company intends to launch in conjunction with Baronsmead Second Venture Trust plc ("BSVT") (the "Offer"), with the Company's investment manager and the Board of BSVT. Having considered the deployment of funds over the past year and the current pipeline of investment opportunities, the Company and BSVT are seeking to raise £15 million each with the discretion to utilise an over-allotment facility of up to a further £10 million each.

The prospectus, which will contain the full details and terms and conditions of the Offer, will be available from www.baronsmeadvcts.co.uk as soon as the Offer is launched, which is expected to be at 9.00am on 13 January 2025. Further details with respect to the Offer will be announced in due course.

 

For further information please contact:

Baronsmead VCT Investor Relations

Telephone - 020 7382 0999

baronsmeadvcts@greshamhouse.com

 

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe for or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefore.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUNOURSWUAUAA
Date   Source Headline
4th Jun 20263:15 pmRNSNet Asset Value(s)
3rd Jun 202610:15 amRNSNewsletter for the period June 2025 to March 2026
1st Jun 202611:28 amRNSTotal Voting Rights
18th May 20263:45 pmRNSAdmission of Further Securities to Trading
14th May 20262:33 pmRNSDirector/PDMR Shareholding
14th May 20262:15 pmRNSAllotment of Shares and Closure of Offer
11th May 20267:00 amRNSNet Asset Value(s)
5th May 20263:15 pmRNSNet Asset Value(s)
1st May 202611:42 amRNSTotal Voting Rights
8th Apr 202610:15 amRNSAdmission of Further Securities to Trading
1st Apr 202611:48 amRNSTotal Voting Rights
31st Mar 20265:38 pmRNSTransaction in Own Shares
24th Mar 20262:20 pmRNSReplacement - Extension to Application Deadline
24th Mar 202612:20 pmRNSApplication Deadline Extension - Fourth Allotment
20th Mar 20267:00 amRNSResult of AGM
5th Mar 20263:30 pmRNSNet Asset Value(s)
2nd Mar 202611:37 amRNSTotal Voting Rights
26th Feb 202612:15 pmRNSAdmission of Further Securities to Trading
20th Feb 202611:02 amRNSDirector/PDMR Shareholding
19th Feb 20264:31 pmRNSAllotment of Shares and Total Voting Rights
16th Feb 20265:15 pmRNSTransaction in Own Shares
10th Feb 20267:00 amRNSOver-Allotment Facility and Offer Update
5th Feb 20264:15 pmRNSNet Asset Value(s)
2nd Feb 20264:45 pmRNSNet Asset Value(s)
2nd Feb 202610:41 amRNSTotal Voting Rights
29th Jan 20263:35 pmRNSAdmission of Further Securities to Trading
22nd Jan 20263:40 pmRNSAllotment of Shares and Total Voting Rights
12th Jan 202611:35 amRNSPublication of a Supplementary Prospectus
23rd Dec 20257:00 amRNSAnnual Financial Report
23rd Dec 20257:00 amRNSAnnual Financial Report
11th Dec 20257:00 amRNSOffer Update:Close of Early Subscription Incentive
4th Dec 20253:45 pmRNSNet Asset Value(s)
1st Dec 202510:45 amRNSTotal Voting Rights
20th Nov 20251:28 pmRNSDirector/PDMR Shareholding
20th Nov 202512:00 pmRNSAllotment of Shares and Total Voting Rights
6th Nov 20254:00 pmRNSNet Asset Value(s)
29th Oct 20259:45 amRNSNet Asset Value(s)
13th Oct 20252:00 pmRNSPublication of a Prospectus/Offer for Subscription
1st Oct 20257:00 amRNSTotal Voting Rights
29th Sep 20255:53 pmRNSTransaction in Own Shares
24th Sep 20259:50 amRNSQuarterly Factsheet June 2025 & Newsletter H2 2025
24th Sep 20258:45 amRNSUpdate on Offer for Subscription
23rd Sep 20252:51 pmRNSQuarterly Factsheet June 2025 & Newsletter H2 2025
11th Sep 20255:08 pmRNSDirector/PDMR Shareholding
9th Sep 20255:59 pmRNSTransaction in Own Shares
4th Sep 20253:15 pmRNSNet Asset Value(s)
4th Sep 20258:15 amRNSIntention to Fundraise
6th Aug 20254:15 pmRNSNet Asset Value(s)
31st Jul 20257:00 amRNSTransaction in Own Shares
28th Jul 202510:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.